1 |
Ashcroft, N.R., Kosinski, M.E., Wickramasinghe, D., Donovan, P.J., and Golden, A. (1998). The four cdc25 genes from the nematode Caenorhabditis elegans. Gene 214, 59-66
DOI
PUBMED
ScienceOn
|
2 |
Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77, 71-94
PUBMED
|
3 |
Clucas, C., Cabello, J., Bussing, I., Schnabel, R., and Johnstone, I.L. (2002). Oncogenic potential of a C. elegans cdc25 gene is demonstrated by a gain-of-function allele. EMBO J. 21, 665-674
DOI
ScienceOn
|
4 |
Draetta, G., and Eckstein, J. (1997). Cdc25 protein phosphatases in cell proliferation. Biochim. Biophys. Acta. 1332, M53-63
PUBMED
|
5 |
Ngan, E.S., Hashimoto, Y., Ma, Z.Q., Tsai, M.J., and Tsai, S.Y. (2003). Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer. Oncogene 22, 734-739
DOI
PUBMED
ScienceOn
|
6 |
Sadhu, K., Reed, S.I., Richardson, H., and Russell, P. (1990). Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2. Proc. Natl. Acad. Sci. USA 87, 5139-5143
DOI
ScienceOn
|
7 |
Imada, K., Lin, N., Liu, C., Lu, A., Chen, W., Yano, M., Sato, T., and Ito, A. (2008). Nobiletin, a citrus polymethoxy flavonoid, suppresses gene expression and production of aggrecanases-1 and -2 in collagen-induced arthritic mice. Biochem. Biophys. Res. Commun. 373, 181-185
DOI
ScienceOn
|
8 |
Kim, S., and Shim, J. (2008). A forward genetic approach for analyzing the mechanism of resistance to the anti-cancer drug, 5- fluorouracil, using Caenorhabditis elegans. Mol. Cells 25, 119-123
PUBMED
|
9 |
Brezak, M.C., Quaranta, M., Mondesert, O., Galcera, M.O., Lavergne, O., Alby, F., Cazales, M., Baldin, V., Thurieau, C., Harnett, J., et al. (2004). A novel synthetic inhibitor of CDC25 phosphatases: BN82002. Cancer Res. 64 3320-3325
DOI
ScienceOn
|
10 |
Galaktionov, K., Lee, A.K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., and Beach, D. (1995). CDC25 phosphatases as potential human oncogenes. Science 269, 1575-1577
DOI
PUBMED
|
11 |
Hebeisen, M., and Roy, R. (2008). CDC-25.1 stability is regulated by distinct domains to restrict cell division during embryogenesis in C. elegans. Development 135, 1259-1269
DOI
ScienceOn
|
12 |
Lee, Y.U., Kawasaki, I., Lim, Y., Oh, W.S., Paik, Y.K., and Shim, Y.H. (2008). Inhibition of developmental processes by flavone in Caenorhabditis elegans and its application to the pinewood nematode, Bursaphelenchus xylophilus. Mol. Cells 26, 171-174
PUBMED
|
13 |
Ullmannova, V., and Popescu, N.C. (2007). Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines. Cancer Detect. Prev. 31, 110-118
DOI
ScienceOn
|
14 |
Xing, X., Chen, J., and Chen, M. (2008). Expression of CDC25 phosphatases in human gastric cancer. Dig. Dis. Sci. 53, 949-953
DOI
ScienceOn
|
15 |
Zhang, Q., Zhao, X.H., and Wang, Z.J. (2008). Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem. Toxicol. 46, 2042-2053
DOI
ScienceOn
|
16 |
Kostic, I., and Roy, R. (2002). Organ-specific cell division abnormalities caused by mutation in a general cell cycle regulator in C. elegans. Development 129, 2155-2165
PUBMED
|
17 |
Ashcroft, N.R., Srayko, M., Kosinski, M.E., Mains, P.E., and Golden,
A. (1999). RNA-Mediated interference of a cdc25 homolog in Caenorhabditis elegans results in defects in the embryonic cortical membrane, meiosis, and mitosis. Dev. Biol. 206, 15-32
DOI
ScienceOn
|
18 |
Hofmann, K., Bucher, P., and Kajava, A.V. (1998). A model of Cdc25 phosphatase catalytic domain and Cdk-interaction surface based on the presence of a rhodanese homology domain. J. Mol. Biol. 282, 195-208
DOI
ScienceOn
|
19 |
Ono, M., Maya, Y., Haratake, M., and Nakayama, M. (2007). Synthesis and characterization of styrylchromone derivatives as beta-amyloid imaging agents. Bioorg. Med. Chem. 15, 444-450
DOI
ScienceOn
|
20 |
Contour-Galcera, M.O., Lavergne, O., Brezak, M.C., Ducommun, B., and Prevost, G. (2004). Synthesis of small molecule CDC25 phosphatases inhibitors. Bioorg. Med. Chem. Lett. 14, 5809-5812
DOI
ScienceOn
|
21 |
Boutros, R., Lobjois, V., and Ducommun, B. (2007). CDC25 phosphatases in cancer cells: key players? Good targets? Nat. Rev. Cancer 7, 495-507
DOI
ScienceOn
|
22 |
Xu, X., Yamamoto, H., Sakon, M., Yasui, M., Ngan, C.Y., Fukunaga, H., Morita, T., Ogawa, M., Nagano, H., Nakamori, S., et al. (2003). Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas. Clin. Cancer Res. 9, 1764-1772
|